LavorgnaLBrigoFMocciaM, et al. e-Health and multiple sclerosis: An update. Mult Scler2018; 24(13): 1657–1664.
2.
FaheemFZafarZRazzakA, et al. Implementing virtual care in neurology – Challenges and pitfalls. J Cent Nerv Syst Dis2022; 14: 1109745.
3.
AlexanderSPeryerGGrayE, et al. Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping review. Mult Scler2021; 27(11): 1643–1656.
4.
HeesenCBergerTRiemann-LorenzK, et al. Mobile health interventions in multiple sclerosis – A systematic review. Mult Scler2023; 2023: 1201089.
5.
FischerASchröderJVettorazziE, et al. An online programme to reduce depression in patients with multiple sclerosis: A randomised controlled trial. Lancet Psychiatry2015; 2(3): 217–223.
6.
PöttgenJMoss-MorrisRWendebourgJM, et al. Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis. J Neurol Neurosurg Psychiatry2018; 89(9): 970–976.
7.
GoldSMFriedeTMeyerB, et al. Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: A multicentre, randomised, controlled, phase 3 trial. Lancet Digit Health2023; 5(10): e668–e678.
8.
BharadiaTVandercappellenJChitnisT, et al. Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?Mult Scler J Exp Transl Clin2022; 8(2): 1105642.
9.
StrijbisEMRepovicPMostertJ, et al. The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials. Mult Scler2022; 28(10): 1606–1619.
10.
CaliendoDPucaALavorgnaL, et al. Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis. Mult Scler J Exp Transl Clin2023; 9(3): 1202123.
